TradeLink Capital LLC Invests $460,000 in Maximus, Inc. (NYSE:MMS)

TradeLink Capital LLC purchased a new position in Maximus, Inc. (NYSE:MMSFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,157 shares of the health services provider’s stock, valued at approximately $460,000. Maximus accounts for approximately 4.5% of TradeLink Capital LLC’s investment portfolio, making the stock its 7th largest holding.

Other hedge funds have also recently modified their holdings of the company. UMB Bank n.a. lifted its position in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the period. Eastern Bank purchased a new stake in shares of Maximus in the 4th quarter worth approximately $29,000. V Square Quantitative Management LLC lifted its position in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock worth $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd purchased a new stake in shares of Maximus in the 4th quarter worth approximately $54,000. Finally, IFP Advisors Inc lifted its position in shares of Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after purchasing an additional 302 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on the stock. StockNews.com lowered shares of Maximus from a “buy” rating to a “hold” rating in a research note on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd.

Get Our Latest Analysis on MMS

Insider Buying and Selling at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Raymond B. Ruddy purchased 3,490 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were bought at an average price of $71.46 per share, for a total transaction of $249,395.40. Following the purchase, the director now directly owns 112,520 shares in the company, valued at $8,040,679.20. This represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 7,008 shares of company stock worth $497,835. 1.60% of the stock is owned by corporate insiders.

Maximus Trading Up 4.8 %

NYSE MMS opened at $71.26 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a market cap of $4.03 billion, a PE ratio of 15.33 and a beta of 0.71. The company has a 50 day moving average price of $72.77 and a 200 day moving average price of $80.22. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, sell-side analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 1.68%. Maximus’s payout ratio is 25.81%.

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.